When health systems fail to proactively reverse metabolic disease, they become part of the metabolic crisis: patients struggle with long-term health complications, providers become overwhelmed, and systems face significant costs, unable to shift to higher-margin value-based care agreements.
This crisis can be averted.
This crisis can be averted.
Acting today on metabolic diseases affecting your patient population is critical. We’ve designed Journeys Metabolic™ to enable health systems, ACO’s, patients, and providers to get ahead—and stay ahead—of this long-term challenge.
Providers, patients, and health systems alike want more proactive, more personalized, more responsive care. But overburdened providers, disengaged patients, and struggling health systems can’t always close this gap.
That’s why we’ve built Journeys Metabolic™.
That’s why we’ve built Journeys Metabolic™ to provide the road map towards value-based care for metabolic disease. Our interoperable system interfaces seamlessly with your existing digital door and takes the burden of metabolic health off of providers and patients.
Journeys Metabolic™ is a comprehensive solution for health systems, providers, and patients. Health systems provide standardized patient care in-home, providers extend their care beyond appointments with zero burden, and patients experience permanent behavior modification.
We built this program to handle the heavy lifting for you.
We built this program to handle the heavy lifting for you, operating as a standalone system without needing excess oversight from your busy providers. Getting started with us is frictionless and starts producing measurable results for your patients, providers, and system right away.
Find out how adding Journeys Metabolic™ to your digital door allows your providers to further extend care into the home, your patients to experience better outcomes, and you to improve quality scores systemwide.
Dr. Hull is a practicing, dual board-certified Adult Internist and Pediatrician with Florida Medical Clinic in Tampa Bay and founder of Journeys Metabolic. She is the founder and co-creator of an evidence-based, clinically proven multidisciplinary wellness program, Well-Being (merged with Readout Health), where she became nationally recognized in the field of metabolic health. Her strategic protocol, focusing on the science of behavior change, has proven effective with over 3,000 patient graduates to both prevent and reverse multiple metabolic disease states, including diabetes and Non-Alcoholic Fatty Liver Disease. As an Associate Professor with the University of South Florida, Dr. Hull conducts clinical research on carbohydrate-restriction and ketogenic nutrition as a metabolic therapy.
Dr. Hull received her medical training at Des Moines University School of Osteopathic Medicine and her Bachelor of Science degree in Food Science and Human Nutrition at the University of Florida. She completed her residency in both Internal Medicine and Pediatrics at the University of South Florida where she was Chief Resident in both Internal Medicine and the combined Internal Medicine-Pediatrics programs. She is board certified both by the American Board of Internal Medicine and American Board of Pediatrics. She is a member of The Gold Humanism Honor Society in recognition of her exemplary service, integrity, clinical excellence, and compassion in patient care.
Kelly is head of metabolic solution development and cofounder of Journeys Metabolic. She cofounded Well-Being with Dr. Allison Hull and co-created the successful intervention 12-week metabolic disease reversal program. For over twenty years, Kelly’s work in the field of Health & Wellness has included program design, development, implementation, and clinical research at Johnson & Johnson, BayCare Health System, and Florida Medical Clinic.
Prior to Journeys Metabolic, Kelly was Co-Founder of Well-Being a Tribe Planted with Purpose a DTC 12-week Metabolic Health Program. As a certified Intrinsic Health Coach, Kelly believes in taking a “whole person” approach to health and empowering individuals to participate actively in their lifelong wellness journey.
Nichole is a 17-year Operations and Quality executive with leadership experience in highly regulated industries including roles at bioMerieux and Pfizer Pharmaceuticals. Her most recent role was VP of Operations at Infinity Labs. As a scientist and executive professional, her background in lab and manufacturing practices, microbiology, chemistry, and method development ensures adherence to quality and regulatory processes at Journeys Metabolic, including developing and maintaining QMS and operational excellence initiatives. Nichole is passionate about bringing those standards and initiatives into the healthcare space to ensure best practices and proven outcomes.
Tim is a biophysicist and sensor scientist, spending his early career in the US National Laboratory system, Lawrence Livermore and Lawrence Berkeley Laboratories developing materials and sensing technologies for chemical, biological, and radiological warfare agents. He was the founder of Readout Health, the fat oxication biomarker device company, after becoming interested in how similar technologies could be applied to improving the human condition, specifically in the measurement of human biomarkers. Tim managed Biosense device support of Journeys programming, as well as the JDRF-funded Journeys Metabolic T1 diabetes clinical trial at Washington University.